Blog

Importing Dantrolene Vials into India: What Shapes the Final Price? Neurology

September 8, 2026

Importing Dantrolene Vials into India: What Shapes the Final Price?

Dantrolene sodium is an important medicine used in the treatment and prevention of malignant hyperthermia…

Dr. Banisetti Sravya

Vemurafenib Availability in Mumbai and Delhi With India-Wide Supply Oncology

September 7, 2026

Vemurafenib Availability in Mumbai and Delhi With India-Wide Supply

For patients undergoing treatment for advanced melanoma, timely access to targeted therapies can be an…

Dr. Banisetti Sravya

Skin Reactions, GI Events & Lab Changes: A Safety Overview of Encorafenib Blog

September 5, 2026

Skin Reactions, GI Events & Lab Changes: A Safety Overview of Encorafenib

This article covers the important aspects of safety issues while taking Encorafenib. This will give…

Dr. Banisetti Sravya

FDA Approves Zanidatamab-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma Oncology

September 1, 2026

FDA Approves Zanidatamab-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

On August 25, 2026, the U.S. Food and Drug Administration (FDA) approved zanidatamab (Ziihera) in…

Dr. Purva Bhandari

What Is Foscarnet Used For? Understanding Its Uses, Treatment & Monitoring Infectious Disease

September 1, 2026

What Is Foscarnet Used For? Understanding Its Uses, Treatment & Monitoring

Foscavir (Foscarnet sodium) is an effective antiviral medication that doesn’t end with dosing but rather…

Dr. Banisetti Sravya

The Complete Guide to Understanding Adagrasib Oncology

August 27, 2026

The Complete Guide to Understanding Adagrasib

You try to convince yourself when your doctor prescribes Krazati and think you are on…

Dr. Banisetti Sravya

Olverembatinib in India: Treatment and Import Access for Patients Oncology

August 26, 2026

Olverembatinib in India: Treatment and Import Access for Patients

Being prescribed a new treatment for chronic myeloid leukemia (CML) can raise practical questions. Why…

Dr. Banisetti Sravya

What to Pack for a Datopotamab Deruxtecan Infusion Day Oncology

August 25, 2026

What to Pack for a Datopotamab Deruxtecan Infusion Day

Are you planning to go to the treatment center for the first time but not…

Dr. Banisetti Sravya

Epcoritamab: 4 Warning Signs You Shouldn’t Brush Aside Oncology

August 22, 2026

Epcoritamab: 4 Warning Signs You Shouldn’t Brush Aside

The common approach towards symptoms is either ignoring it or panicking too much but neither…

Dr. Banisetti Sravya

Cancer Is Clever. Here’s Why Encorafenib Has Backup ImmunologyOncology

August 21, 2026

Cancer Is Clever. Here’s Why Encorafenib Has Backup

Cancer is smart enough to increase its population. Never expected, right? It doesn’t play by…

Dr. Banisetti Sravya